Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

83.62 -0.40 (-0.48%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Boston Scientific Narrowly Tops Second-Quarter Expectations; Shares Surge
Boston Scientific now expects full-year sales to grow 8%-9% organically. 
Via Investor's Business Daily
Boston Scientific: Q2 Earnings Insights
  Boston Scientific (NYSE:BSX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Medtronic Stock Keeps Ticking Forward
Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year. 
Via MarketBeat
Topics Economy
Exposures COVID-19 Supply Chain
Tuesday's Market Minute: Tech Heavyweight Earnings On Deck: GOOGL, MSFT, META, AMZN, AAPL
U.S. equities wobbled to start arguably the busiest week of earnings of the quarter. Monday kicked off the final week of trading for the month of July, and despite initial overall weakness... 
Via Benzinga
Boston Scientific Buys Substantial Stake In Korean MedTech Player
Via Benzinga
Where Boston Scientific Stands With Analysts
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Apple To $185? Plus This Analyst Lowers Price Target On Amazon.com
  Jefferies cut the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $163 to $150. However, Jefferies analyst Brent Thill maintained a Buy rating on the stock. Amazon shares rise 2.5% to trade at... 
Via Benzinga
Accenture And 3 Other Stocks Insiders Are Selling
Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
What 7 Analyst Ratings Have To Say About Boston Scientific
Over the past 3 months, 7 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.8% on an annualized basis producing an average annual return of 20.73%. Currently, Boston Scientific has a market... 
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Boston Scientific's (NYSE:BSX) short percent of float has risen 25.0% since its last report. The company recently reported that it has 19.02 million shares sold short, which is 1.... 
Via Benzinga
5 Analysts Have This to Say About Boston Scientific
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Boston Scientific Jumps On Upbeat Q2, FY22 Guidance
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market... 
Via Benzinga
5 Analysts Have This to Say About Boston Scientific
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.09% on an annualized basis producing an average annual return of 20.41%. Currently, Boston Scientific has a market... 
Via Benzinga
Peering Into Boston Scientific's Recent Short Interest
Boston Scientific's (NYSE:BSX) short percent of float has risen 20.45% since its last report. The company recently reported that it has 15.00 million shares sold short, which... 
Via Benzinga
Boston Scientific Details How It Is Advancing Equity in Workplaces, Health Care Systems and Communities While Taking Action for a Healthier Planet
SOURCE: Boston Scientific 
Via 3BL Media
If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today
Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market... 
Via Benzinga
This Foreboding Sign Looms Over Boston Scientific's Chart
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the... 
Via Benzinga
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook
Via Benzinga
Boston Scientific Ekes Out A Narrow First-Quarter Beat, Offers So-So Sales Guide
Boston Scientific narrowly topped first-quarter expectations and offered sales guidance that just met forecasts. BSX stock popped. 
Via Investor's Business Daily
Recap: Boston Scientific Q1 Earnings
Boston Scientific (NYSE:BSX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Boston Scientific reported... 
Via Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering... 
Via Benzinga
Goldman Sachs And 3 Other Stocks Insiders Are Selling
Although gold futures traded lower this morning on Friday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Health remains a tricky investment area, but Evercore analysts say there are safe bets. 
Via Investor's Business Daily
CNBC's Final Trades: Amazon, FedEx And These Health Care Picks
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors said that Amazon.com, Inc. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.